IOYIForum Profile Banner
IOYIF Profile
IOYIF

@IOYIForum

Followers
414
Following
550
Media
210
Statuses
471

July 29-31, 2021 • Drs. Mario Sznol, Cath Bollard • Partner @sitcancer • Presented by @cec_onc • Grant: AstraZeneca

Houston, TX
Joined October 2016
Don't wanna be here? Send us removal request.
@NBCIBlackChurch
NatlBlkChrchInitive
10 months
Opioid Early Career Scholar Program⁠ ⁠ An intensive multi-day opioid REMS initiative in Pain Management⁠ ⁠ Register Today⁠ ⁠ Early Bird Deadline: February 14th⁠ March 15-16, 2025⁠ Wyndham Garden Lake Buena Vista ⁠ Buena Vista, FL⁠ ⁠ @cmeoutfitters #health #wellness
1
9
11
@zaidheartsci
Faisal Scientist
11 months
@CEC_Onc @PGrivasMDPhD @DanielPetrylak Must-attend for oncologists and urologists! Excited to expand my knowledge on ADCs and adverse events. #CME #MedEd
0
9
9
@breathofhopeky
Breath of Hope Kentucky
2 years
Keeping these young investigators engaged & supported in their important work gives patients continued hope for a better tomorrow. Our future depends on progress. We are thankful for these mentors and this platform! @EGFRSummit #ResearchMatters #anyonewithlungs
@EGFRResisters
EGFR Resisters
2 years
Watch now - EGFR Resisters 5th Annual Research Summit Wrap Up w/ commentary from @StephenVLiu & @ivybelkins. Congratulations to the young investigators! Thank you @CE_Concepts for sponsoring this event! @EGFRSummit #lcam #lcsm https://t.co/OBAuuyfAIu
0
9
7
@IOYIForum
IOYIF
2 years
#ALLYIF2023 DAY 1
@EGFRSummit
EGFR Resisters Research Summit
2 years
#ALLYIF2023 DAY 1
0
0
2
@IOYIForum
IOYIF
2 years
Looking to present your research??
@ALLYIForum
ALLYIForum
2 years
Submit your abstract for the #ALLYIF 2023! 📈 Improve your #Research Skills 🏆 Research awards range from $1k-$4k DEADLINE to submit is OCTOBER 15➡ https://t.co/U4PWRwCPxK #HematologyResearch #OncologyResearch
0
0
1
@IOYIForum
IOYIF
2 years
Look at who ran into each in the wild at #ASCO23? 2⃣ fantastic #IOYIF21 alumni! @BraunMDPhD @thenasheffect 🙌
@BraunMDPhD
David Braun
2 years
Lucky to run into old friends @thenasheffect from our time @IOYIForum #ASCO23
1
0
13
@IOYIForum
IOYIF
3 years
Immuno-oncology Young Investigators! Join us LIVE online or in-person at #SITC22 Nov 11th at 6:00pm ET & earn 1.0 CME Credit! Our faculty panel will discuss the power of immunotherapy in HCC & BTC! Register for in-person/online here ➡️ https://t.co/cKuVN369uX
0
3
5
@juanosoriomd
Juan C Osorio MD
3 years
Extremely grateful @BWFUND for the support!!! Also thankful for the amazing mentorship, it really makes a difference. Also congrats to all the fellow awardees!
@BWFUND
BWFUND
3 years
The Burroughs Wellcome Fund is pleased to announce the recipients of the 2022 Career Award for Medical Scientists https://t.co/SZodpqLKii #bwfcams #bwfrtp
1
4
37
@IOYIForum
IOYIF
3 years
Excited to see so many @IOYIForum faculty & alums involved with this @sitcancer series! @MSznol @Vignali_Lab @BcellBruno @aaronmring #LAG3 #IL18 #TIL #Bcell https://t.co/90ujaVDvig
0
0
4
@IOYIForum
IOYIF
3 years
Shout out to an amazing @IOYIForum alum, @thenasheffect! 🎉🎉
@thenasheffect
Rafeh Naqash, MD, FASCO
3 years
Honored to be part of and learn from this group of featured voices @ASCO. Will try my best to highlight #ASCO22 sessions on Dev Therapeutics/ IO Biomarkers/ irAEs/ Lung. @ShannonWestin @neerajaiims @DrBetofMDPhD @crisbergerot @AnaVManana @fumikochino @IshwariaMD others
0
0
5
@quirogad
Dionisia Quiroga, DO, PhD, FASCO
3 years
Honored to be included as an ASCO YIA recipient this year for my work on systemic inflammation in people experiencing #lymphedema following breast cancer tx! Also so happy to be sharing this experience with @OSUCCC_James co-fellows @JasmineSukumar & Nate Denlinger!
@ConquerCancerFd
Conquer Cancer, the ASCO Foundation
3 years
#ASCO22 is less than two weeks away, and we’ll be awarding more than $12 million in support to these and other incredible cancer researchers! Special thanks to Conquer Cancer donors, and congratulations to the recipients of our 2022 Grants & Awards! #cancerresearch #oncology
10
6
45
@BraunMDPhD
David Braun
4 years
The Center of Molecular and Cellular Oncology (CMCO) @YaleMed @YaleCancer is hiring a Program Manager! https://t.co/kuT1S5Om5g
1
4
10
@IOYIForum
IOYIF
4 years
Congrats to our alumni and awardee, @BraunMDPhD! 🎉 #IOYIF21
@ASCOPost
The ASCO Post
4 years
David Braun, MD, PhD, Joins Prostate and Urologic Cancers Program at Yale Cancer Center https://t.co/qfIbDPpf2O @YaleCancer @BraunMDPhD
0
2
18
@IOYIForum
IOYIF
4 years
Congrats @thenasheffect on the nomination! Proud to see our alums being recognized! Be sure to congratulate Dr. Naquash at ASCO! 🙌🙌🙌
@thenasheffect
Rafeh Naqash, MD, FASCO
4 years
Deeply honored to have been nominated and selected for 2022 class of #40 under #40 in Oncology 🙂 @StephensonCC @OUHealth @sitcancerECS Join us for the reception and ceremony on June 4 #ASCO22 😊
1
1
9
@JennGuerriero
Jennifer Guerriero, PhD
4 years
Thank you #AACR2022 for an incredible week of science, friends and food. You even brought #Tcells and #macrophages together. Heard among friends in this photo: “it’s not all about the Tcell”. @JimAllisonPhD @MiriamMerad @PamSharmaMDPhD
4
8
104
@Vignali_Lab
Vignali Lab
4 years
So excited to see FDA approval of the first anti-LAG3, in combination with anti-PD1! It has been a long road but we have had the pleasure of working with an amazing team of trainees and collaborators dissecting LAG3 function since ~2020 (20+ papers)! 1/2
Tweet card summary image
news.bms.com
Opdualag is a first-in-class, fixed-dose dual immunotherapy combination treatment of the PD-1 inhibitor nivolumab and novel LAG-3-blocking antibody relatlimab1 In RELATIVITY-047, Opdualagmore than...
5
27
274
@BraunMDPhD
David Braun
4 years
Out in @NEJM this week, our perspective on some recent outstanding work defining the phenotype of tumor-infiltrating T cells across cancer types, and our thoughts on next steps. Tumor-Infiltrating T Cells — A Portrait | NEJM https://t.co/WoAI49kbFT @YaleCancer @YaleMed
Tweet card summary image
nejm.org
Genetic landscaping and T cells are all the rage when it comes to tumor biology. Put them together and you get a comprehensive view of the T cell in the context of different types of cancer. The au...
5
99
391
@EGFRSummit
EGFR Resisters Research Summit
4 years
We would like to extend a THANK YOU to Rosemary Ostmann from @rosecomm & @ivybelkins from @EGFRResisters for sharing all of their insights on best practices to becoming a digital opinion leader during last Friday’s webinar. 💻🔎 See a few of the topics below! #DOL #MedTwitter
0
6
16
@IOYIForum
IOYIF
4 years
Our webinar on best practices to becoming a digital opinion leader is this Fri 1/21 @ 12p! Reply to this tweet w/ your Q's on best practices as a trusted source & hear from communications expert @rosecomm answer your Q's. Click ⬇️ & reserve your spot! https://t.co/iVuwKO53uV
@IOYIForum
IOYIF
4 years
Hey YIF Alums! What are you most curious about in becoming a trusted source for science in the age of digital media? 🤔Join us on Fri 1/21 @ 12p to see how you can increase the reach of your research.🌐 Click ⬇️to register for this can’t miss session! https://t.co/iVuwKOmEmt
0
1
7